![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CCDC47-TERT (FusionGDB2 ID:HG57003TG7015) |
Fusion Gene Summary for CCDC47-TERT |
![]() |
Fusion gene information | Fusion gene name: CCDC47-TERT | Fusion gene ID: hg57003tg7015 | Hgene | Tgene | Gene symbol | CCDC47 | TERT | Gene ID | 57003 | 7015 |
Gene name | coiled-coil domain containing 47 | telomerase reverse transcriptase | |
Synonyms | GK001|MSTP041|THNS | CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT | |
Cytomap | ('CCDC47')('TERT') 17q23.3 | 5p15.33 | |
Type of gene | protein-coding | protein-coding | |
Description | coiled-coil domain-containing protein 47Calumin | telomerase reverse transcriptasetelomerase catalytic subunittelomerase-associated protein 2 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000225726, ENST00000403162, ENST00000582252, | ||
Fusion gene scores | * DoF score | 6 X 5 X 5=150 | 22 X 7 X 15=2310 |
# samples | 6 | 31 | |
** MAII score | log2(6/150*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(31/2310*10)=-2.89755273102918 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CCDC47 [Title/Abstract] AND TERT [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CCDC47(61850772)-TERT(1282739), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | TERT | GO:0001172 | transcription, RNA-templated | 19701182 |
Tgene | TERT | GO:0006278 | RNA-dependent DNA biosynthetic process | 9398860 |
Tgene | TERT | GO:0007004 | telomere maintenance via telomerase | 9443919|16043710|17940095|19701182|21531765|29695869 |
Tgene | TERT | GO:0007005 | mitochondrion organization | 21937513 |
Tgene | TERT | GO:0010629 | negative regulation of gene expression | 11927518 |
Tgene | TERT | GO:0022616 | DNA strand elongation | 16043710 |
Tgene | TERT | GO:0030422 | production of siRNA involved in RNA interference | 19701182 |
Tgene | TERT | GO:0031647 | regulation of protein stability | 24415760|26194824 |
Tgene | TERT | GO:0032092 | positive regulation of protein binding | 24415760 |
Tgene | TERT | GO:0051000 | positive regulation of nitric-oxide synthase activity | 11927518 |
Tgene | TERT | GO:0070200 | establishment of protein localization to telomere | 25589350 |
Tgene | TERT | GO:0071897 | DNA biosynthetic process | 9398860|19701182 |
Tgene | TERT | GO:1903704 | negative regulation of production of siRNA involved in RNA interference | 19701182 |
Tgene | TERT | GO:1904751 | positive regulation of protein localization to nucleolus | 24415760 |
Tgene | TERT | GO:2000773 | negative regulation of cellular senescence | 11927518 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ACC | TCGA-OR-A5JS-01A | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
Top |
Fusion Gene ORF analysis for CCDC47-TERT |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000225726 | ENST00000296820 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000225726 | ENST00000310581 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000225726 | ENST00000334602 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000225726 | ENST00000508104 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000403162 | ENST00000296820 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000403162 | ENST00000310581 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000403162 | ENST00000334602 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000403162 | ENST00000508104 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000582252 | ENST00000296820 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000582252 | ENST00000310581 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000582252 | ENST00000334602 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-3CDS | ENST00000582252 | ENST00000508104 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-intron | ENST00000225726 | ENST00000522877 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-intron | ENST00000403162 | ENST00000522877 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
5UTR-intron | ENST00000582252 | ENST00000522877 | CCDC47 | chr17 | 61850772 | - | TERT | chr5 | 1282739 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CCDC47-TERT |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for CCDC47-TERT |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:61850772/:1282739) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CCDC47-TERT |
![]() |
Top |
Fusion Gene PPI Analysis for CCDC47-TERT |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CCDC47-TERT |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CCDC47-TERT |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CCDC47 | C0343073 | Wooly hair | 1 | GENOMICS_ENGLAND |
Hgene | CCDC47 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | CCDC47 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Hgene | CCDC47 | C4021780 | Abnormality of the liver | 1 | GENOMICS_ENGLAND |
Hgene | CCDC47 | C4748898 | TRICHOHEPATONEURODEVELOPMENTAL SYNDROME | 1 | GENOMICS_ENGLAND |
Tgene | C3151443 | DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2 | 11 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C3553617 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1 | 8 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0002874 | Aplastic Anemia | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0265965 | Dyskeratosis Congenita | 5 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1800706 | Idiopathic Pulmonary Fibrosis | 5 | CTD_human;ORPHANET | |
Tgene | C4721508 | Hamman-Rich Disease | 5 | CTD_human | |
Tgene | C4721509 | Usual Interstitial Pneumonia | 5 | CTD_human | |
Tgene | C4721952 | Familial Idiopathic Pulmonary Fibrosis | 5 | CTD_human | |
Tgene | C2239176 | Liver carcinoma | 4 | CTD_human | |
Tgene | C0023467 | Leukemia, Myelocytic, Acute | 3 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1148551 | X-Linked Dyskeratosis Congenita | 3 | CTD_human | |
Tgene | C1956346 | Coronary Artery Disease | 3 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0017638 | Glioma | 2 | CTD_human | |
Tgene | C0024121 | Lung Neoplasms | 2 | CTD_human | |
Tgene | C0025202 | melanoma | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0030297 | Pancreatic Neoplasm | 2 | CTD_human | |
Tgene | C0033578 | Prostatic Neoplasms | 2 | CTD_human | |
Tgene | C0242379 | Malignant neoplasm of lung | 2 | CTD_human | |
Tgene | C0259783 | mixed gliomas | 2 | CTD_human | |
Tgene | C0334488 | Clear cell sarcoma of kidney | 2 | ORPHANET | |
Tgene | C0346647 | Malignant neoplasm of pancreas | 2 | CTD_human | |
Tgene | C0348890 | Aplastic anemia, idiopathic | 2 | ORPHANET | |
Tgene | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human | |
Tgene | C0555198 | Malignant Glioma | 2 | CTD_human | |
Tgene | C1846142 | HOYERAAL-HREIDARSSON SYNDROME | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET | |
Tgene | C3554574 | MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9 | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human | |
Tgene | C0005695 | Bladder Neoplasm | 1 | CTD_human | |
Tgene | C0006142 | Malignant neoplasm of breast | 1 | CTD_human | |
Tgene | C0006826 | Malignant Neoplasms | 1 | CTD_human | |
Tgene | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human | |
Tgene | C0007873 | Uterine Cervical Neoplasm | 1 | CTD_human | |
Tgene | C0010054 | Coronary Arteriosclerosis | 1 | CTD_human | |
Tgene | C0010314 | Cri-du-Chat Syndrome | 1 | CTD_human | |
Tgene | C0022658 | Kidney Diseases | 1 | CTD_human | |
Tgene | C0023448 | Lymphoid leukemia | 1 | CTD_human | |
Tgene | C0023473 | Myeloid Leukemia, Chronic | 1 | CTD_human | |
Tgene | C0023903 | Liver neoplasms | 1 | CTD_human | |
Tgene | C0024115 | Lung diseases | 1 | GENOMICS_ENGLAND | |
Tgene | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human | |
Tgene | C0027022 | Myeloproliferative disease | 1 | CTD_human | |
Tgene | C0027651 | Neoplasms | 1 | CTD_human | |
Tgene | C0027819 | Neuroblastoma | 1 | CTD_human | |
Tgene | C0035126 | Reperfusion Injury | 1 | CTD_human | |
Tgene | C0040136 | Thyroid Neoplasm | 1 | CTD_human | |
Tgene | C0041696 | Unipolar Depression | 1 | PSYGENET | |
Tgene | C0085786 | Hamman-Rich syndrome | 1 | ORPHANET | |
Tgene | C0086692 | Benign Neoplasm | 1 | CTD_human | |
Tgene | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human | |
Tgene | C0178416 | Hypoplastic anemia | 1 | CTD_human | |
Tgene | C0206686 | Adrenocortical carcinoma | 1 | CTD_human | |
Tgene | C0235874 | Disease Exacerbation | 1 | CTD_human | |
Tgene | C0242380 | Libman-Sacks Disease | 1 | CTD_human | |
Tgene | C0345904 | Malignant neoplasm of liver | 1 | CTD_human | |
Tgene | C0549473 | Thyroid carcinoma | 1 | CTD_human | |
Tgene | C0678222 | Breast Carcinoma | 1 | CTD_human | |
Tgene | C0919267 | ovarian neoplasm | 1 | CTD_human | |
Tgene | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human | |
Tgene | C1269683 | Major Depressive Disorder | 1 | PSYGENET | |
Tgene | C1368275 | Pigmented Basal Cell Carcinoma | 1 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 1 | CTD_human | |
Tgene | C2314896 | Familial Atypical Mole Melanoma Syndrome | 1 | ORPHANET | |
Tgene | C3151444 | DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4 | 1 | GENOMICS_ENGLAND | |
Tgene | C4048328 | cervical cancer | 1 | CTD_human | |
Tgene | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human | |
Tgene | C4721806 | Carcinoma, Basal Cell | 1 | CTD_human |